Ernesta Cavalcanti

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 16

Top Topics

Squamous Cell Carcinoma

Radical Prostatectomy

Prognostic Factors

Top Venues

Journal of translational medicine

Blood cancer journal

Pharmaceuticals (Basel, Switzerland)

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Renato de Falco, Giulia Togo, Anita Minopoli, Marco Cuomo, Domenica Rea, Serena Meola, Ernesta Cavalcanti
Prevalence and distribution of M-proteins in the oncologic population affected by solid tumor. Blood cancer journal 14 (1) (2024)
Renato de Falco, Giulia Togo, Anita Minopoli, Marco Cuomo, Domenica Rea, Serena Meola, Ernesta Cavalcanti
Prevalence and distribution of M-proteins in the oncologic population affected by solid tumor. Blood cancer journal 14 (1) (2024)
Alessandra Bracigliano, Antonella Lucia Marretta, Luigi Pio Guerrera, Roberto Simioli, Ottavia Clemente, Vincenza Granata, Anita Minopoli, Giuseppina Della Vittoria Scarpati, Fernanda Picozzi, Lucia Cannella, Antonio Pizzolorusso, Francesca Di Gennaro, Roberto Tafuto, Maria Rosaria Sarno, Ernesta Cavalcanti, Dario Ribera, Salvatore Tafuto
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Alessandra Bracigliano, Antonella Lucia Marretta, Luigi Pio Guerrera, Roberto Simioli, Ottavia Clemente, Vincenza Granata, Anita Minopoli, Giuseppina Della Vittoria Scarpati, Fernanda Picozzi, Lucia Cannella, Antonio Pizzolorusso, Francesca Di Gennaro, Roberto Tafuto, Maria Rosaria Sarno, Ernesta Cavalcanti, Dario Ribera, Salvatore Tafuto
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Renato de Falco, Giulia Togo, Anita Minopoli, Marco Cuomo, Domenica Rea, Serena Meola, Ernesta Cavalcanti
Prevalence and distribution of M-proteins in the oncologic population affected by solid tumor. Blood cancer journal 14 (1) (2024)
Alessandra Bracigliano, Antonella Lucia Marretta, Luigi Pio Guerrera, Roberto Simioli, Ottavia Clemente, Vincenza Granata, Anita Minopoli, Giuseppina Della Vittoria Scarpati, Fernanda Picozzi, Lucia Cannella, Antonio Pizzolorusso, Francesca Di Gennaro, Roberto Tafuto, Maria Rosaria Sarno, Ernesta Cavalcanti, Dario Ribera, Salvatore Tafuto
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Domenico Galati, Domenico Mallardo, Carmine Nicastro, Serena Zanotta, Ludovica Capitelli, Carmen Lombardi, Bianca Baino, Ernesta Cavalcanti, Silvia Sale, Francesco Labonia, Rita Boenzi, Luigi Atripaldi, Paolo Antonio Ascierto, Marialuisa Bocchino
The Dysregulation of the Monocyte-Dendritic Cell Interplay Is Associated with In-Hospital Mortality in COVID-19 Pneumonia. Journal of clinical medicine 13 (9) (2024)
Domenico Galati, Domenico Mallardo, Carmine Nicastro, Serena Zanotta, Ludovica Capitelli, Carmen Lombardi, Bianca Baino, Ernesta Cavalcanti, Silvia Sale, Francesco Labonia, Rita Boenzi, Luigi Atripaldi, Paolo Antonio Ascierto, Marialuisa Bocchino
The Dysregulation of the Monocyte-Dendritic Cell Interplay Is Associated with In-Hospital Mortality in COVID-19 Pneumonia. Journal of clinical medicine 13 (9) (2024)
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Domenico Mallardo, Mario Fordellone, Andrew White, Margaret Ottaviano, Francesca Sparano, Michael D Bailey, Arianna Bianca Facchini, Sufey Ong, Piera Maiolino, Corrado Caracò, Sarah Church, Ernesta Cavalcanti, Sarah Warren, Alfredo Budillon, Alessandra Cesano, Ester Simeone, Paolo Chiodini, Paolo Antonio Ascierto
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy. Journal of translational medicine 21 (1) (2023)
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Domenico Mallardo, Diana Giannarelli, Maria Grazia Vitale, Domenico Galati, Giusy Trillò, Assunta Esposito, Maria Antonietta Isgrò, Grazia D'Angelo, Lucia Festino, Vito Vanella, Claudia Trojaniello, Andrew White, Teresa De Cristofaro, Michael Bailey, Sandro Pignata, Corrado Caracò, Antonella Petrillo, Paolo Muto, Piera Maiolino, Alfredo Budillon, Sarah H Warren, Ernesta Cavalcanti, Paolo Antonio Ascierto
Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis. Journal for immunotherapy of cancer 10 (11) (2022)
Ernesta Cavalcanti, Maria Antonietta Isgrò, Domenica Rea, Lucia Di Capua, Giusy Trillò, Luigi Russo, Gerardo Botti, Leonardo Miscio, Franco Maria Buonaguro, Attilio Antonio Montano Bianchi
Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy). Infectious agents and cancer 16 (1) (2021)
Ernesta Cavalcanti, Vittoria Barchiesi, Dionigio Cerasuolo, Flaviano Di Paola, Monica Cantile, Sabrina Chiara Cecere, Sandro Pignata, Alessandro Morabito, Raffaele Costanzo, Massimo Di Maio, Francesco Perrone
Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy. Analytical cellular pathology (Amsterdam) 2016 (2016)